PROTAC ERα Degrader-1 comprises an ubiquitin E3 ligase binding group, a linker and a protein binding group. PROTAC ERα Degrader-1 extracts from patent WO2017201449A1, compound P1. PROTAC ERα Degrader-1 is an estrogen receptor-alpha (ERα) degrader.
性状
Solid
IC50 & Target[1][2]
Estrogen receptor-alpha (ERα)
体外研究(In Vitro)
Treatment of the HER2 expressing cells with the PROTAC ERα Degrader-1 (without Ab; compound P1) results in a decreased estrogen receptor-alpha (ERα) levels. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
参考文献
[1]. Thomas Pillow, et al. Protac antibody conjugates and methods of use. WO2017201449A1.
溶解度数据
In Vitro: DMSO : 200 mg/mL (178.53 mM; Need ultrasonic)配制储备液